CV Sciences holder reports 13.1% stake, 26.6M shares
Large holder Charles E. Cheever III reports beneficial ownership of 13.1% of CV Sciences’ common stock with sole voting and dispositive power.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CV Sciences, Inc. (CVSI) has a large shareholder, Charles E. Cheever III, reporting beneficial ownership of a significant block of its common stock on a Schedule 13G. He reports beneficial ownership of 26,648,711 shares of common stock, representing 13.1% of the class.
Cheever reports sole voting and dispositive power over all 26,648,711 shares and no shared power. This total includes 881,700 shares held by a trust for which he is trustee; he states he has no personal pecuniary interest in those trust shares, but they are included due to his voting and dispositive authority as trustee.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Sole Dispositive Power financial
pecuniary interest financial
trustee financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of CVSI’s common stock does Charles E. Cheever III beneficially own?
What class of CVSI securities is covered by this Schedule 13G filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.